Nano Letters,
Journal Year:
2024,
Volume and Issue:
24(17), P. 5301 - 5307
Published: April 16, 2024
The
accurate
diagnosis
of
diabetic
nephropathy
relies
on
achieving
ultrasensitive
biosensing
for
biomarker
detection.
However,
existing
biosensors
face
challenges
such
as
poor
sensitivity,
complexity,
time-consuming
procedures,
and
high
assay
costs.
To
address
these
limitations,
we
report
a
WS
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(7), P. 3605 - 3605
Published: March 23, 2024
Diabetic
nephropathy
(DN)
is
a
serious
complication
of
diabetes,
and
its
progression
influenced
by
factors
like
oxidative
stress,
inflammation,
cell
death,
fibrosis.
Compared
to
drug
treatment,
exercise
offers
cost-effective
low-risk
approach
slowing
down
DN
progression.
Through
multiple
ways
mechanisms,
helps
control
blood
sugar
pressure
reduce
serum
creatinine
albuminuria,
thereby
alleviating
kidney
damage.
This
review
explores
the
beneficial
effects
on
improvement
highlights
potential
mechanisms
for
ameliorating
DN.
In-depth
understanding
role
mechanism
in
improving
would
pave
way
formulating
safe
effective
programs
treatment
prevention
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(8), P. 4350 - 4350
Published: April 15, 2024
Diabetes
is
not
solely
a
metabolic
disorder
but
also
involves
inflammatory
processes.
The
immune
response
it
incites
primary
contributor
to
damage
in
target
organs.
Research
indicates
that
during
the
initial
phases
of
diabetic
nephropathy,
macrophages
infiltrate
kidneys
alongside
lymphocytes,
initiating
cascade
reactions.
interplay
between
and
other
renal
cells
pivotal
advancement
kidney
disease
within
hyperglycemic
milieu.
While
M1
react
stimuli
induced
by
elevated
glucose
levels
early
progression,
their
subsequent
transition
M2
macrophages,
which
possess
anti-inflammatory
tissue
repair
properties,
contributes
fibrosis
later
stages
nephropathy
transforming
into
myofibroblasts.
Comprehending
diverse
functions
regulating
activity
could
offer
therapeutic
benefits
for
managing
this
condition.
Non-Coding RNA,
Journal Year:
2024,
Volume and Issue:
10(3), P. 30 - 30
Published: May 3, 2024
Chronic
kidney
disease
(CKD)
represents
an
increasing
health
burden.
Evidence
suggests
the
importance
of
miRNA
in
diagnosing
CKD,
yet
reports
are
inconsistent.
This
study
aimed
to
determine
novel
biomarkers
and
potential
therapeutic
targets
from
hypothesis-free
profiling
studies
human
murine
CKDs.
Comprehensive
literature
searches
were
conducted
on
five
databases.
Subgroup
analyses
diseases,
sample
types,
stages,
species
conducted.
A
total
38
12
eligible
analyzed
using
Robust
Rank
Aggregation
(RRA)
vote-counting
analyses.
Gene
set
enrichment
signatures
each
DIANA-miRPath
v4.0
MIENTURNET.
As
a
result,
top
target
genes,
Ontology
terms,
interaction
network
between
molecular
pathways
identified.
According
analysis,
145
miRNAs
dysregulated
32
CKD
models.
By
RRA,
miR-26a-5p
was
significantly
reduced
tissue
Lupus
nephritis
(LN),
while
miR-107
decreased
LN
patients’
blood
samples.
In
both
species,
epithelial-mesenchymal
transition,
Notch,
mTOR
signaling,
apoptosis,
G2/M
checkpoint,
hypoxia
most
enriched
pathways.
These
their
genes
must
be
validated
large
patient
cohort
studies.
Nano Letters,
Journal Year:
2024,
Volume and Issue:
24(17), P. 5301 - 5307
Published: April 16, 2024
The
accurate
diagnosis
of
diabetic
nephropathy
relies
on
achieving
ultrasensitive
biosensing
for
biomarker
detection.
However,
existing
biosensors
face
challenges
such
as
poor
sensitivity,
complexity,
time-consuming
procedures,
and
high
assay
costs.
To
address
these
limitations,
we
report
a
WS